title: Reply: To PMID 24914476.
authors.affiliation: *Retina Consultants of Houston, Weill Cornell Medical College, Houston Methodist Hospital, Houston, Texas †Retina Consultants of Houston, Houston, Texas.
authors.forename: David M
authors.initials: DM
authors.lastname: Brown
authors.forename: Charles C
authors.initials: CC
authors.lastname: Wykoff
authors.forename: Daniel E
authors.initials: DE
authors.lastname: Croft
authors.forename: Tien P
authors.initials: TP
authors.lastname: Wong
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007511:Ischemia / Q000188:drug therapy*; D008297:Male; D012170:Retinal Vein Occlusion / Q000188:drug therapy*; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A